https://www.selleckchem.com/pr....oducts/defactinib.ht
The Foundation Fighting Blindness, RDH12 family organizations, and the RDH12 Fund for Sight convened a jointly organized workshop in Columbia, Maryland, on November 19, 2019. The purpose of the workshop was to share perspectives on what is known about the RDH12-associated retinal dystrophies (RDs) and discuss the advancement of therapies, primarily gene therapy, for people with mutations in the RDH12 gene which cause Leber congenital amaurosis 13 (LCA13). The workshop began with presentations on the RDH12 landscape, patient perspecti
Like
Comment
Share
